| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |